These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 30268711)

  • 1. Tumor-parenchyma interface and long-term oncologic outcomes after robotic tumor enucleation for sporadic renal cell carcinoma.
    Minervini A; Campi R; Di Maida F; Mari A; Montagnani I; Tellini R; Tuccio A; Siena G; Vittori G; Lapini A; Raspollini MR; Carini M
    Urol Oncol; 2018 Dec; 36(12):527.e1-527.e11. PubMed ID: 30268711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathologic analysis of non-neoplastic parenchyma in renal cell carcinoma: a comprehensive observation in radical nephrectomy specimens.
    Wang X; Liu Q; Kong W; Huang J; Chen Y; Huang Y; Zhang J
    BMC Cancer; 2017 Dec; 17(1):900. PubMed ID: 29282004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histopathologic analysis of peritumoral pseudocapsule and surgical margin status after tumor enucleation for renal cell carcinoma.
    Minervini A; di Cristofano C; Lapini A; Marchi M; Lanzi F; Giubilei G; Tosi N; Tuccio A; Mancini M; della Rocca C; Serni S; Bevilacqua G; Carini M
    Eur Urol; 2009 Jun; 55(6):1410-8. PubMed ID: 18692300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Five-year Oncologic Outcomes After Transperitoneal Robotic Partial Nephrectomy for Renal Cell Carcinoma.
    Andrade HS; Zargar H; Caputo PA; Akca O; Kara O; Ramirez D; Haber GP; Stein RJ; Kaouk JH
    Eur Urol; 2016 Jun; 69(6):1149-54. PubMed ID: 26719014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histopathologic analysis of tumor bed and peritumoral pseudocapsule after in vitro tumor enucleation on radical nephrectomy specimen for clinical T1b renal cell carcinoma.
    Lu Q; Ji C; Zhao X; Fu Y; Guo S; Liu G; Zhang S; Li X; Gan W; Guo H
    Urol Oncol; 2017 Oct; 35(10):603.e15-603.e20. PubMed ID: 28619631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathological characteristics and prognostic effect of peritumoral capsule penetration in renal cell carcinoma after tumor enucleation.
    Minervini A; Rosaria Raspollini M; Tuccio A; Di Cristofano C; Siena G; Salvi M; Vittori G; Sebastianelli A; Lapini A; Serni S; Carini M
    Urol Oncol; 2014 Jan; 32(1):50.e15-22. PubMed ID: 24239462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncologic outcomes in patients treated with endoscopic robot assisted simple enucleation (ERASE) for renal cell carcinoma: Results from a tertiary referral center.
    Mari A; Di Maida F; Tellini R; Campi R; Sforza S; Cocci A; Siena G; Vittori G; Tuccio A; Masieri L; Lapini A; Raspollini MR; Carini M; Minervini A
    Eur J Surg Oncol; 2019 Oct; 45(10):1977-1982. PubMed ID: 30981447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive Surgical Margins Predict Progression-free Survival After Nephron-sparing Surgery for Renal Cell Carcinoma: Results From a Single Center Cohort of 459 Cases With a Minimum Follow-up of 5 Years.
    Tellini R; Antonelli A; Tardanico R; Fisogni S; Veccia A; Furlan MC; Carobbio F; Cozzoli A; Zanotelli T; Simeone C
    Clin Genitourin Cancer; 2019 Feb; 17(1):e26-e31. PubMed ID: 30266249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Open partial nephrectomy for entirely intraparenchymal tumors: a matched case-control study of oncologic outcome and complication rate.
    Zapala P; Dybowski B; Miazek N; Radziszewski P
    Int Braz J Urol; 2017; 43(2):209-215. PubMed ID: 28128905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Robotic partial nephrectomy for clinical stage T1b tumors: intermediate oncologic and functional outcomes.
    Maddox M; Mandava S; Liu J; Boonjindasup A; Lee BR
    Clin Genitourin Cancer; 2015 Feb; 13(1):94-9. PubMed ID: 25176501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of the current status of tumor enucleation for renal cell carcinoma.
    Minervini A; Tuccio A; Lapini A; Lanzi F; Vittori G; Siena G; Tosi N; Serni S; Carini M
    Arch Ital Urol Androl; 2009 Jun; 81(2):65-71. PubMed ID: 19760858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma.
    Psutka SP; Feldman AS; McDougal WS; McGovern FJ; Mueller P; Gervais DA
    Eur Urol; 2013 Mar; 63(3):486-92. PubMed ID: 22959191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncologic outcomes of patients with positive surgical margin after partial nephrectomy: a 25-year single institution experience.
    Petros FG; Metcalfe MJ; Yu KJ; Keskin SK; Fellman BM; Chang CM; Gu C; Tamboli P; Matin SF; Karam JA; Wood CG
    World J Urol; 2018 Jul; 36(7):1093-1101. PubMed ID: 29488096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anatomic comparison of traditional and enucleation partial nephrectomy specimens.
    Calaway AC; Gondim DD; Flack CK; Jacob JM; Idrees MT; Boris RS
    Urol Oncol; 2017 May; 35(5):221-226. PubMed ID: 28153421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Oncologic Outcomes After Laparoscopic and Robotic Tumor Enucleation for Renal Cell Carcinoma.
    Dong W; Chen X; Huang M; Chen X; Gao M; Ou D; Li K; Wang C; Wu S; Liu H; Xie W; Xie W; Campbell SC; Lin T; Huang J
    Front Oncol; 2020; 10():595457. PubMed ID: 33520708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical enucleation for renal cell carcinoma (RCC). Prognostic significance of tumour stage, grade and DNA ploidy.
    Di Silverio F; Sciarra A; Flammia GP; Mariani M; De Vico A; Buscarini M
    Scand J Urol Nephrol; 1997 Apr; 31(2):123-8. PubMed ID: 9165573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Robotic nephrectomy for central renal tumors with intraoperative evaluation of tumor histology.
    Lieberman L; Barod R; Tapper A; Kumar R; Rogers C
    J Robot Surg; 2016 Sep; 10(3):261-5. PubMed ID: 27146858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility and Safety of Robotic Excision of Ipsilateral Retroperitoneal Recurrence After Nephrectomy for Renal Cell Carcinoma.
    Ghandour R; Miranda AF; Singla N; Meng X; Enikeev D; Woldu S; Bagrodia A; Cadeddu J; Gahan J; Margulis V
    Urology; 2020 Nov; 145():159-165. PubMed ID: 32828868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Standardized Reporting of Microscopic Renal Tumor Margins: Introduction of the Renal Tumor Capsule Invasion Scoring System.
    Snarskis C; Calaway AC; Wang L; Gondim D; Hughes I; Idrees MT; Kliethermes S; Maniar V; Picken MM; Boris RS; Gupta GN
    J Urol; 2017 Jan; 197(1):23-30. PubMed ID: 27497792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peritumoral pseudocapsule status according to pathological characteristics from robot-assisted laparoscopic partial nephrectomy for localized renal cell carcinoma.
    Takagi T; Yoshida K; Kondo T; Kobayashi H; Iizuka J; Okumi M; Ishida H; Nagashima Y; Tanabe K
    Int J Urol; 2019 Apr; 26(4):446-450. PubMed ID: 30650470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.